Panacea brings seasoned clinical research professionals with specialist expertise to each of its assignments. We have multi-therapeutic experience in domestic and international Phase I-IV pharmaceutical studies, as well as pilot, pivotal and post market medical device studies. No matter the size, scope or duration of the study, we are successful at organizing and implementing a complete clinical trial process to accelerate the development and submission of your medical product.

Lawrence W. Yarmaloff, President & Principal Consultant
After working in the clinical research field for many years, Lawrence W. Yarmaloff founded Panacea Clinical Research over a decade ago. Mr. Yarmaloff has over twenty years of experience in the clinical development of investigational therapeutic products. He started his clinical research career by coordinating clinical trials and research laboratory testing for the Department of Histocompatability and Immunogenetics at Brigham and Women’s Hospital, and then by subsequently joining Quintiles, Inc. as a Clinical Research Associate. Following his tenure at Quintiles, he moved through ascending positions in project and therapeutic area management in the biotechnology arena with ImmunoGen, Inc. He then reentered the CRO venue by joining Paragon Biomedical, Inc. as a regionally based consultant and employee providing project management and monitoring services and leadership in the company’s quality and training initiatives.

Mr. Yarmaloff holds a Bachelor’s Degree in Chemistry from Bates College and is accredited by the Associates of Clinical Research Professionals as a Certified Clinical Research Associate (CCRA). He is an active member of DIA (Drug Information Association) and ACRP (Associates of Clinical Research Professionals – national and local chapters).